ADC Therapeutics S.A.
ADC Therapeutics S.A. (ADCT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ADCT · as of Jun 8, 2026
Activity summary
Buy transactions
3
P-Purchase only
Sell transactions
6
12 Months
Buy/Sell ratio
0.50
Buy/Sell (by trades)
Overall sentiment
ADC Therapeutics S.A. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ADCT insider buying and selling by quarter
ADCT insider selling · ADCT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ADCT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ADCT executive sell shares · ADCT board member insider trading · ADCT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 31, 2026 | Redmile Group, LLC 10 percent owner | Sale | 196,229 | $736K | Form 4 |
| Apr 1, 2026 | Redmile Group, LLC 10 percent owner | Sale | 169,265 | $643K | Form 4 |
| Mar 31, 2026 | Redmile Group, LLC 10 percent owner | Sale | 188,407 | $707K | Form 4 |
| Apr 1, 2026 | Redmile Group, LLC 10 percent owner | Sale | 162,517 | $617K | Form 4 |
| Apr 2, 2026 | Redmile Group, LLC 10 percent owner | Sale | 2,634,506 | $8.64M⚡ | Form 4 |
| Apr 2, 2026 | Redmile Group, LLC 10 percent owner | Sale | 2,529,491 | $8.29M⚡ | Form 4 |
Redmile Group, LLC
10 percent owner
Date
Mar 31
Shares
196,229
Price
$3.75
Value
$736K
Redmile Group, LLC
10 percent owner
Date
Apr 1
Shares
169,265
Price
$3.80
Value
$643K
Redmile Group, LLC
10 percent owner
Date
Mar 31
Shares
188,407
Price
$3.75
Value
$707K
Redmile Group, LLC
10 percent owner
Date
Apr 1
Shares
162,517
Price
$3.80
Value
$617K
Redmile Group, LLC
10 percent owner
Date
Apr 2
Shares
2,634,506
Price
$3.28
Value
$8.64M ⚡
Redmile Group, LLC
10 percent owner
Date
Apr 2
Shares
2,529,491
Price
$3.28
Value
$8.29M ⚡
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ADCT insider trading
ADCT insider trades
ADC Therapeutics S.A. (ADCT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Redmile Group, LLC (10 percent owner). Over the past 12 months, 1 insiders have filed transactions with the SEC. ADCT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For ADC Therapeutics S.A.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ADCT insider trading · 5 questionsThe insiders of ADC Therapeutics S.A. (ADCT) include executives and directors such as Redmile Group, LLC (10 percent owner), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026